2012
DOI: 10.1021/jm3001295
|View full text |Cite
|
Sign up to set email alerts
|

Rationally Designing Safer Anilines: The Challenging Case of 4-Aminobiphenyls

Abstract: We describe how we have been able to design 4-aminobiphenyls that are nonmutagenic (inactive in the Ames test). No such 4-aminobiphenyls were known to us, but insights provided by quantum mechanical calculations have permitted us to design and synthesize some examples. Importantly, the quantum mechanical calculations could be combined with predictions of other properties of the compounds that contained the 4-aminobiphenyls so that these remained druglike. Having found compounds that are not active, the calcula… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
35
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 47 publications
(37 citation statements)
references
References 34 publications
2
35
0
Order By: Relevance
“…In the absence of an instruction manual of medicinal chemistry, which would describe how to change the structure of a compound to transform it into a drug, the practitioner must adhere to broad "rules" and theoretical principles. These necessitate playing safe and although no "transgressions against medicinal chemistry rules" might be made such as "never make an aniline" [18], by avoid challenging assumptions, they may also result in avoiding innovative solutions [19]. In an alternative extreme strategy, the practitioner may choose to believe in the "exceptionalism of the drug", the "special" molecule that balances the conflicting properties; once this can be found, all will be well.…”
Section: Human Aspectsmentioning
confidence: 99%
“…In the absence of an instruction manual of medicinal chemistry, which would describe how to change the structure of a compound to transform it into a drug, the practitioner must adhere to broad "rules" and theoretical principles. These necessitate playing safe and although no "transgressions against medicinal chemistry rules" might be made such as "never make an aniline" [18], by avoid challenging assumptions, they may also result in avoiding innovative solutions [19]. In an alternative extreme strategy, the practitioner may choose to believe in the "exceptionalism of the drug", the "special" molecule that balances the conflicting properties; once this can be found, all will be well.…”
Section: Human Aspectsmentioning
confidence: 99%
“…The initial focus of structural changes in the aminoheterocycle portion of the molecule was on larger N-ethyl (32) and N-isopropyl pyrazoles (33) ( Table 1.12). These groups maintained GK activity but unfortunately both 1-ethyl-3-aminopyrazole and its isopropyl homologue were active in the Ames test.…”
Section: Mitigating Fragment Mutagenicity Concerns and Developing A Pmentioning
confidence: 99%
“…This reaction is considered likely to be subject to similar energetic considerations as the transformations involving generation of electrophilic species that are able to react with DNA [32] (Figure 1.19).…”
Section: Mitigating Fragment Mutagenicity Concerns and Developing A Pmentioning
confidence: 99%
See 1 more Smart Citation
“…They are widely used in the production of bioactive natural products, pharmaceuticals, agricultural chemicals, and so on. [1][2][3] As a result, there are many methods for the synthesis of aromatic amines, and among these, reduction of nitroaromatics by hydrogenation is the most commonly used method. So far, many methods based on earth-abundant metal-mediated reductions have also been described, such as those using well-known Fe/HCl, Zn/NaOH, LiAlH 4 , and so on.…”
Section: Introductionmentioning
confidence: 99%